Population Pharmacokinetic Model of N -acetylmannosamine (ManNAc) and N -acetylneuraminic acid (Neu5Ac) in Subjects with GNE Myopathy

ConclusionsThis population pharmacokinetic model can be used to evaluate ManNAc dosing regimens and to calculate Neu5Ac production and exposure following oral administration of ManNAc in subjects with GNE myopathy.
Source: Drugs in R&D - Category: Drugs & Pharmacology Source Type: research